Medicare AdvantageReimbursementMedium impact
MA00.058, Reimbursement of Surgical Pathology Services for Prostate Biopsy
Independence Blue Cross·Urology, Pathology, Oncology·Claims & Billing
Effective date
Mar 2, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage has established a new policy MA00.058 specifically addressing reimbursement requirements for surgical pathology services related to prostate biopsies. This policy will standardize how these pathology services are billed and reimbursed for Medicare Advantage members.
Action Required
Before March 2, 2026: Billing team must review and update billing procedures for prostate biopsy pathology services to comply with new Medicare Advantage policy MA00.058. Contact Medicare Advantage representatives to obtain specific billing requirements and documentation standards. Update billing software and staff training materials accordingly.